Dr. Wei Feng 封巍
Chief Physician
Department of Thoracic Radiation Oncology, Zhejiang Cancer Hospital, Hangzhou
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Radiation therapy for esophageal, lung, and breast cancers, and comprehensive treatment of thoracic tumors.
Dr. Feng is a Chief Physician with a PhD in Radiation Oncology from Hebei Medical University (2005). A former visiting scholar at Shizuoka Cancer Center, Japan, Dr. Feng researches combining radiation with chemotherapy and targeted therapies for esophageal and lung cancers. Dr. Feng has published over 20 papers, edited three books, and holds more than 20 national invention patents.
Professional roles
- Member, Radiobiology Group, Radiation Oncology Branch, Chinese Medical Association
- Member, Esophageal Cancer Working Committee, Chinese Cooperative Group for Oncology Radiotherapy
- Member, Lung Tumor Professional Committee, China Medicine Education Association
- Member, Lung Cancer Professional Committee, UCOM
Name order: in Chinese the family name comes first (Feng Wei). Papers usually list the name as Wei Feng or Feng W.
Selected publications
26 papers on PubMed matched by name and affiliation; 8 as first or senior author since 2016. Most recent first- or senior-author papers:
- Discov Oncol, 2026 (senior author): pH responsive nanoplatforms for radiosensitization and radioprotection in cancer therapy. PubMed 42678484
- Front Oncol, 2026 (senior author): Carbon ion radiotherapy and radiation-induced lung injury: clinical evidence, mechanistic insights, and future directions. PubMed 42294345
- World J Gastrointest Oncol, 2026 (senior author): Efficacy and safety of immune checkpoint inhibitors plus chemotherapy in esophageal cancer patients with liver metastases. PubMed 41607764
- Front Oncol, 2025 (senior author): Development of a predictive model for radiation pneumonitis based on plasma exosomal miR-200b-5p. PubMed 40909958
- J Thorac Dis, 2024 (senior author): Enhancing outcomes in extensive-stage small cell lung cancer brain metastases: a retrospective study on the synergistic effects of immune checkpoint inhibitor, brain radiotherapy, and chemotherapy. PubMed 39444875
- Asia Pac J Clin Oncol, 2022 (first author): Current status of total neoadjuvant therapy for locally advanced rectal cancer. PubMed 34818447
- Chin J Cancer Res, 2020 (senior author): Prognostic factors affecting long-term outcomes in patients with brain metastasis from esophageal carcinoma. PubMed 33446999
- J Int Med Res, 2020 (first author): Risk factors for tumor recurrence in patients with pT(3)N(0)M(0) thoracic esophageal squamous cell carcinoma after esophagectomy. PubMed 33290111
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital. This name is shared by other researchers, so we checked that most papers list this doctor's hospital and department.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion